Veracyte (VCYT) Total Liabilities (2012 - 2026)

Veracyte (VCYT) has 15 years of Total Liabilities data on file, last reported at $92.0 million in Q1 2026.

• Quarterly Total Liabilities fell 23.64% year-over-year to $92.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92.0 million (down 23.64% YoY) and the FY2025 annual result came in at $96.4 million, down 22.27% from the prior year.
• Total Liabilities declined to $92.0 million in Q1 2026 per VCYT's latest filing, from $96.4 million in the prior quarter.
• The five-year high for Total Liabilities was $124.1 million in Q4 2024, with the low at $70.8 million in Q4 2023.
• Average Total Liabilities over 5 years is $92.5 million, with a median of $88.4 million recorded in 2022.
• Year-over-year, Total Liabilities soared 75.23% in 2024 and dropped 23.64% in 2026.
• Veracyte's Total Liabilities stood at $81.2 million in 2022, then slipped by 12.83% to $70.8 million in 2023, then surged by 75.23% to $124.1 million in 2024, then slipped by 22.27% to $96.4 million in 2025, then fell by 4.61% to $92.0 million in 2026.
• Business Quant data shows VCYT's Total Liabilities at $92.0 million in Q1 2026, $96.4 million in Q4 2025, and $110.1 million in Q3 2025.